Brochures Overview
DMPK studies characterize the absorption, distribution, metabolism, and excretion (ADME) properties of compounds, to help identify drugs with better safety and potency against a target, reduce the risk of drug-drug interactions, and provide a basis for clinical dosage and frequency setting.
WuXi AppTec DMPK is primarily responsible for in vivo and in vitro pharmacokinetic studies. When you partner with WuXi AppTec for drug discovery and development services, you gain access to an integrated worldwide network of facilities that offer a full range of discovery screening, preclinical development, clinical drug metabolism, and pharmacokinetic platforms and services.
Complete the form to view and download this brochure.
Stay Connected
Keep up with the latest news and insights.